Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy.
about
Novel Biological Approaches for Testing the Contributions of Single DSBs and DSB Clusters to the Biological Effects of High LET RadiationDNA double-strand-break complexity levels and their possible contributions to the probability for error-prone processing and repair pathway choiceRadiation survivors: understanding and exploiting the phenotype following fractionated radiation therapyDrugging the Cancers Addicted to DNA Repair.Carbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/RepairTelomere profiling: toward glioblastoma personalized medicine.Comparison of the light charged particles on scatter radiation dose in thyroid hadron therapy.The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells.DNA repair mechanisms in cancer development and therapyCarbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro.Detection of DNA-protein crosslinks (DPCs) by novel direct fluorescence labeling methods: distinct stabilities of aldehyde and radiation-induced DPCs.DNA Damage Response Proteins and Oxygen Modulate Prostaglandin E2 Growth Factor Release in Response to Low and High LET Ionizing Radiation.Photon, light ion, and heavy ion cancer radiotherapy: paths from physics and biology to clinical practice.Improving cancer therapy by combining cell biological, physical, and molecular targeting strategies.Particle therapy for cancers: a new weapon in radiation therapy.Future radiation therapy: photons, protons and particles.The electromagnetic spectrum: current and future applications in oncology.Activation of local and systemic anti-tumor immune responses by ablation of solid tumors with intratumoral electrochemical or alpha radiation treatments.TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.Early effects comparison of X-rays delivered at high-dose-rate pulses by a plasma focus device and at low dose rate on human tumour cells.Nitric oxide increases the invasion of pancreatic cancer cells via activation of the PI3K-AKT and RhoA pathways after carbon ion irradiation.Radioprotective effects of selenium and vitamin-E against 6MV X-rays in human blood lymphocytes by micronucleus assay.Effect of densely ionizing radiation on cardiomyocyte differentiation from human-induced pluripotent stem cells.The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining.Targeting DNA repair with PNKP inhibition sensitizes radioresistant prostate cancer cells to high LET radiation.E2F is involved in radioresistance of carbon ion induced apoptosis via Bax/caspase 3 signal pathway in human hepatoma cell.Fra‑1 enhances the radioresistance of colon cancer cells to X‑ray or C‑ion radiation.Could hyperthermia with proton therapy mimic carbon ion therapy? Exploring a thermo-radiobiological rationale
P2860
Q26742111-F328F25E-3591-48B5-80DD-F046B7C9F3E2Q27014837-AEE6F507-2424-4FAC-B675-36D0E2502F49Q27026696-A6615CEE-F80A-4B5B-B0C5-C84544891978Q33702497-DC2BCABA-6B6B-48FF-88C4-B09CA4154B32Q33832767-496453F7-D32F-45F2-8CCB-B3A3D1781B06Q34445288-B2C50A3E-C6E2-44F1-8AC4-498531C9F65CQ34649937-674BB18B-A86B-4E3A-B534-84F591E30099Q35236805-3B7D5388-5E0C-49F8-AF34-11B8202E03D9Q35531287-7F972004-2653-430E-87CF-8BD4A44A0FBEQ36027858-7148EF1D-7F8E-42C8-BB1A-22F10AF0869EQ36305588-267EDCBC-6199-46A1-AC95-F743BCB09D86Q36349712-C6F62B1D-C5EE-4A75-A82F-C3ADE2EC7B1FQ36403877-7057A348-6CB4-4490-A1C9-B159A06234CAQ36563213-F1138851-D59D-4EB9-BE0B-140A325B9334Q38008951-32220650-EE1C-42D3-9823-EE12E16B3529Q38096409-4B9FE93F-272D-44BC-99BE-A3C032C382F8Q38104411-A12DAFE1-220B-4ABC-9A1B-72160A912EFFQ38129794-64120CBC-6B29-4865-BA46-A330367059C5Q38722571-C0D788FB-D734-458B-94B7-14C1D7D7B8A8Q38885963-C3AC124A-7A94-408E-997C-DBE01429B986Q38975626-A7C90D2A-05C5-4BBD-AE4B-B3444E22B993Q39521339-01AA7209-370E-468C-B374-EECD4DF7DEBBQ41385806-1E379C26-B7FE-4B1B-ADEB-2CD923E812D6Q41656985-15FB9F68-B108-4E1D-B6D7-E3CBDA1C5DB7Q48043803-B0E03151-B9F1-4FAD-894F-4FE34AFB4AB7Q48149214-5085C55F-8A97-4EEE-A9FF-10FDF30324CDQ49331625-22CCE988-C3BA-491A-9CDF-9E12F310EA2AQ58417822-1101CF92-4B52-48F5-9BE7-C606B1B43D3E
P2860
Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Heavy charged particle radiobi ...... ing to advance cancer therapy.
@ast
Heavy charged particle radiobi ...... ing to advance cancer therapy.
@en
type
label
Heavy charged particle radiobi ...... ing to advance cancer therapy.
@ast
Heavy charged particle radiobi ...... ing to advance cancer therapy.
@en
prefLabel
Heavy charged particle radiobi ...... ing to advance cancer therapy.
@ast
Heavy charged particle radiobi ...... ing to advance cancer therapy.
@en
P2093
P2860
P1433
P1476
Heavy charged particle radiobi ...... ing to advance cancer therapy.
@en
P2093
Christopher Allen
Hirohiko Tsujii
Jac A Nickoloff
Thomas B Borak
P2860
P304
P356
10.1016/J.MRFMMM.2011.02.012
P407
P577
2011-03-03T00:00:00Z